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ABSTRACT
In this review article, data are collected regarding the various derivatives of coumarin and oxadiazole as both these have wide range of biological 
activities and they can be further modified to synthesize more effective and potent drugs. Coumarin class of organic compounds consists of 
1,2-benzopyrone ring system as a basic parent scaffold. These benzopyrones are subdivided into alpha-benzopyrones and gamma-benzopyrones; 
with coumarin class of compounds belonging to alpha-benzopyrones, coumarins were synthesized in many of their derivative forms since the last 
few years. Their pharmacological, therapeutic, and biochemical properties depend on their pattern of substitution. Coumarins exhibit a wide range of 
pharmacological activities, which includes antidiabetic, antiviral, antimicrobial, anticancer, antioxidant, antiparasitic, antiproliferative, anticonvulsant, 
anti-inflammatory and antihypertensive activities, and anti-helminthic. 1,3,4-oxadiazole is a heterocyclic compound containing an oxygen atom and 
two nitrogen atoms in a five-membered ring. It is derived from furan by substitution of two methylene groups with two pyridine type nitrogens. 
There are three known isomers: 1,2,3-oxadiazole, 1,2,4-oxadiazole, and 1,2,5-oxadiazole. Oxadiazole moiety shows antimicrobial, anticancer, and 
anti-inflammatory activity and suitably substituted 1,3,4-oxadiazole having biological activities such as antimicrobial, anticancer, and other biological 
activities.
Keywords: Coumarin derivatives, Oxadiazole derivatives, Biological activities, 1,3,4-oxadiazole, Hybrids.
INTRODUCTION
As per the WHO reports, more than 10 million cancer cases occurred 
worldwide since 2002. This situation would get worse to 15 million 
over the next 20 years [1]. It can occur at all ages but more common 
with old age. Cancer results from uncontrolled growth of normal cells, 
so cancer cells closely resemble normal cells. Most of the drugs used in 
the treatment of cancer act against all rapidly proliferating cells, and 
therefore, along with the cancer cells, they also affect the normal cells. 
The most common problem in the cancer treatment is to kill the cancer 
cells selectively with no or less side effects [2].
Coumarins are fused benzene and pyrone ring systems which prompt 
biological investigation to assess their potential therapeutic significance. 
It contains good anticancer potential with minimum side effects 
depending on the substitutions on the basic nucleus. Coumarins have 
a tremendous ability to regulate diverse range of cellular pathways 
that can be explored for selective anticancer activity [3]. Coumarin is 
a natural substance that has shown antitumor activity in vivo, with the 
effect believed to be due to its metabolites such as 7-hydroxycoumarin. 
Therefore, the focus will be on these relevant compounds and their 
therapeutic importance. A recent study has shown that coumarin-
substituted benzothiazole inhibits the protein tyrosine kinase. This 
knowledge may lead to its use in cancer therapy. The most recent work 
involves 2 cell lines, MCF-7 a breast carcinoma and A549 lung carcinoma.
1,3,4-oxadiazole is a heterocyclic compound containing two nitrogen 
atoms and an oxygen atom in a five-membered ring. It is derived from 
furan by substitution of two methylene groups (=CH) with two pyridine 
type nitrogens (-N=). There are three known isomers: 1,2,4-oxadiazole, 
1,2,3-oxadiazole, and 1,2,5-oxadiazole. Oxadiazole moiety shows 
anticancer, antimicrobial, and anti-inflammatory activity and suitably 
substituted 1,3,4-oxadiazole having biological activities such as 
antimicrobial, anticancer, and other biological activities. This work 
focused to develop efficient synthetic strategies to afford structurally 
diverse chalcone derivatives having improved antimicrobial activities by 
attaching other lead structure like oxadiazole heterocyclic moieties [4].
CHEMISTRY OF COUMARIN AND OXADIAZOLE
The fusion of benzene nucleus with pyrone ring gives rise to a class of 
heterocyclic compound known as benzopyrone with two distinct types 
recognized as benzo-α-pyrone (Fig. 1) commonly called as coumarin 
and benzo-γ-pyrone (Fig. 2) commonly called as chromon. They are 
different from each other only in the position of carbonyl group in 
heterocyclic ring. There are several methods which are developed for 
the synthesis of coumarin, such as the Pechmann, Perkin, Knoevenagel, 
Witting, and Reformastsky reaction. Among these, the Pechmann 
reaction has been the most widely used method in the synthesis 
of coumarin since it proceeds from very simple starting materials 
and gives good yield of variously substituted coumarin. Pechmann 
reaction consists of condensation of β-ketonic ester with phenol to give 
coumarin [5].
Oxadiazoles and their derivatives are simple five-membered 
heterocycles possessing one oxygen and two nitrogen atoms. The 
oxadiazoles exist in different isomeric forms such as 1,2,4-, 1,2,5-, 
1,2,3-, and 1,3,4-oxadiazoles.
 
The five-member heterocyclic compounds containing nitrogen 
and oxygen heterocycles, particularly oxadiazoles have been 
successfully tested against several diseases and therefore received 
special attention in pharmaceutical chemistry due to their diverse 
medicinal potential. Among the oxadiazoles; 1,2,4-oxadiazoles 
continuously draws interest for the development of newer drug 
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moiety. Substituted 1,3,4-oxadiazole derivatives have shown a broad 
spectrum of biological properties in pharmaceutical field. Among 
heterocyclic compounds, 1,3,4-oxadiazole has become an important 
construction for the development of new drugs. Compounds 
containing 1,3,4-oxadiazole cores have a broad biological activity 
spectrum including antibacterial, antifungal, analgesic, anti-
inflammatory, antiviral, anticancer, antihypertensive, anticonvulsant, 
and antidiabetic properties. They have also attracted interest in 
medicinal chemistry as surrogates (bioisosteres) for carboxylic 
acids, esters, and carboxamides [6]. The ability of 1,3,4-oxadiazole 
heterocyclic compounds to undergo various chemical reactions 
has made them important for molecule planning because of their 
privileged structure, which has enormous biological potential. 
Two examples of compounds containing the 1,3,4-oxadiazole unit 
currently used in clinical medicine are Raltegravir®, an antiretroviral 
drug [7] and Zibotentan®, an anticancer agent [8]. Other market 
formulations are nesapidil, and furamizole. Oxadiazole is a very 
weak base due to the inductive effect of the extra-heteroatom. 
The replacement of two CH= groups in furan by two pyridine type 
nitrogen (N=) reduces aromaticity of resulting oxadiazole ring 
to such an extent that the oxadiazole ring exhibits character of 
conjugated diene. Electrophilic substitutions in oxadiazole ring 
are extremely difficult at the carbon atom because of the relatively 
low-electron density on the carbon atom which can be attributed 
to electron withdrawal effect of the pyridine type nitrogen atom. 
However, the attack of electrophiles occurs at nitrogen if oxadiazole 
ring is substituted with electron releasing groups. Oxadiazole ring 
is generally resistant to nucleophilic attack. Halogen-substituted 
oxadiazole, however, undergoes nucleophilic substitution with the 
replacement of halogen atom by nucleophiles. Oxadiazole undergoes 
nucleophilic substitution similarly as occurring at an aliphatic sp2 
carbon atom [9].
VARIOUS SYNTHETIC PATHWAYS OF COUMARIN AND OXADIAZOLE 
DERIVATIVES
Coumarins can be obtained by different extraction methods from the 
plants such as maceration under sonication, infusion, and supercritical 
fluid extraction. However, the extraction from plants is time-consuming 
and tedious job; hence, there is a need for sophisticated instrument for 
separation process to get the pure product. Chemically, coumarins can 
be synthesized by various methods such as the Pechmann reaction, 
Knoevenagel condensation, Claisen rearrangement, Perkin, Wittig, 
Reformatsky, and catalytic cyclization reactions.
Perkin reaction
The chemical synthesis of coumarin was first achieved by Perkin. 
In this reaction, Perkin used salicylaldehyde as synthon. Coumarin 
was obtained by heating salicylaldehyde with acetic anhydride and 
anhydrous sodium acetate. This reaction proceeds through the 
formation of an intermediated o-hydroxycinnamic acid derivative 
which converts spontaneously into the lactone ring [10].
Pechmann reaction
The reaction of a phenol with malic acid in the presence of concentrated 
sulfuric acid leads to the formation of hydroxyl phenyl coumarin 
derivatives. Many substituted phenols do not undergo this reaction; 
only coumarins unsubstituted in the pyrone ring are obtained [11].
Pechmann-Duisberg reaction
Pechmann and Duisberg found that phenols condense with para-ketonic 
esters in the presence of sulfuric acid, giving coumarin derivatives. This 
reaction has found extensive applications in the synthesis of various 
coumarin derivatives [12].
Knoevenagel reaction
This process is based on the synthesis of coumarin derivatives obtained 
from o-hydroxy (aryl/phenyl) aldehydes by condensation with ethyl 
malonate, ethyl acetoacetate, ethyl cyanoacetate, etc., in the presence of 
piperidine, pyridine, and other organic bases [13].
Witting reaction
In the Wittig reaction, the alkene formation takes place from carbonyl 
compounds and phosphonium ylides, proceeding primarily through 
betaine and/or oxaphosphetane intermediates. This type of olefination 
of o-hydroxycarbonyl aromatic compounds followed by lactonization is 
a well-known method for the preparation of coumarin derivatives [14].
The synthesis of heterocyclic compounds involves multistructure in 
a molecule. The condensation reaction involves cyclization or ring 
formation. There are two free positions for the substitution in the 
oxadiazole heterocyclic ring system. 5-substituted-2-(2-methyl-4-
nitro-1-imidazomethyl)-1,3,4-oxadiazoles were prepared by both 
microwave-assisted and conventional method of synthesis. The 
starting material 2-methyl-4-nitro-imidazole, used in the preparation 
of hydrazide, was obtained commercially. The 5-aryl-2-(2-methyl-
4-nitro-1-imidazomethyl)-1,3,4-oxadiazoles were prepared by the 
microwave irradiation of 2-methyl-4-nitro-1-imidazo acetohydrazide, 
with appropriate carboxylic acids in the presence of phosphorous 
oxychloride [15].
Similarly, the reaction was also carried out by the conventional method 
by refluxing an intimate mixture of hydrazide with an appropriate 
carboxylic acid in phosphrous oxychloride in an oil bath. Reactions of 
4-substituted benzoic acid derivatives with (N-isocyanimino)-triphenyl 
phosphorane proceed smoothly at room temperature to lead to the 
corresponding 2-aryl-1,3,4-oxadiazoles through an intramolecular 
aza-Wittig reaction. Several synthetic methods have been reported for 
the preparation of (N-isocyanimino)-triphenyl phosphorane. There are 
several reports for the use of (N-isocyanimino)-triphenyl phosphorane 
in the synthesis of metal complexes. 2-Aryl-1,3,4-oxadiazole 
derivatives were prepared from 4-substituted benzoic acid derivatives 
and (N-isocyanimino)-triphenyl phosphorane in excellent yields 
under neutral conditions [16]. A suspension of salicylic hydrazide/
thiosalicylic acid was prepared with toluene and acetic anhydride or 
with an acid chloride and an equimolar quantity of methanesulfonic 
acid. The suspension was refluxed at room temperature to give 
1,3,4-oxadiazoles. Treatment of salicylic semicarbazides, which were 
readily obtainable by the reaction of salicylic hydrazide/thiosalicylic 
acid with isocyanates, under Appel’s dehydration condition (Ph3P/
CCl4/Et3N) smoothly afforded 1,3,4-oxadiazoles through carbodiimide 
intermediates followed by intramolecular cyclization reaction and 
hydride shift [17].
Synthesis of 3-carbethoxy coumarin salicylaldehyde and ethyl malonate 
was dissolved in absolute ethanol and to this mixture was added 
piperidine and glacial acetic acid. This mixture was heated under 
refluxed. The hot solution was transferred to an Erlenmeyer flask. Hot 
water was added to the solution, the product crystallized out rapidly 
as the solution cooled, the mixture was stirred from time to time as 
crystallization proceeded, and stored overnight in a refrigerator. The 
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and dried in air. Mol. Wt. 218; Yield: 82%; M.p: 245 0C; Rf. value: 0.65 
(Ethyl acetate: acetone [9;1]) ; IR:(KBr v cm-1); 3090 (aromatic C-H 
stretching), 1680(C=O, coumarin), 1750(C=O ester), 1131(C-O ester), 
800 (aromatic C-H bend).1H NMR (CDCl3) δ ppm1HNMR (DMSO) δ ppm: 
2.4 (2H, CH3); 3.4(2H, OCH2: 6.2-8.2 (Ar-H, 9H) Mass- M+ synthesis 
of 2 – oxo – 2H – chromene -3 – carbohydrazide peak (m/z)218, Base 
peak (m/z)145 [18].
BIOLOGICAL ACTIVITIES OF COUMARIN AND OXADIAZOLE
Coumarin
Kinase inhibitors
Kinases are those enzymes that catalyze the transfer of a phosphate 
group to the target protein. They play a critical role in the modulation 
of growth factor signaling. Activated forms of these enzymes can cause 
increase in cell proliferation, promote angiogenesis, prevent apoptosis 
and metastasis in several cancers, and their activation by the somatic 
mutation is a basic mechanism of tumor genesis. As all these effects 
are initiated by the activation of kinases, they are the key targets for 
inhibition by coumarins and their derivatives [19].
Cell cycle arrest
Coumarins are useful in arresting various phases of cell cycle such as 
G0, G1, S, and M phase that will eventually lead to apoptosis. They are 
found to initiate apoptosis by caspase-dependent intrinsic pathway and 
alteration in the cellular level of Bcl-2 family proteins [20]. Mitochondrial 
potential gets highly depleted due to an increased expression of 
proapoptotic Bax/Bak and intracellular reactive oxygen species. 
Further this, it results in release of cytochrome c from the mitochondria 
which lowers the matrix metalloproteinase and translocates into the 
cytoplasm with the activation of initiator caspase-9 and extracellular 
caspases-3/7. Tumour suppressor proteins p53 and its transcriptional 
target PUMA are upregulated. PUMA interacts with anti-apoptotic Bcl-2 
family proteins, promotes the activation of Bax/Bak, and has necessary 
role in multiple apoptotic models [21].
Angiogenesis inhibitors
Coumarin derivatives also act through angiogenesis. They have been 
found to prevent angiogenesis by inhibiting fibroblast growth factor-
2-mediated proliferation, migration, and tubule formation. Coumarin 
derivatives were also observed to decrease the expression of vascular 
endothelial growth factor at mRNA level through nuclear factor-κB and 
phosphorylation of IKKα; interestingly, with this phosphatidylinositide 
3-kinases (PI-3K)/Akt, signalling pathway remains unaffected [22].
HSP90 inhibitors
A number of experiments are already been carried out and many are 
still going in progress to inhibit all the eight hallmarks of cancer by 
targeting HSP90. Coumarins are found to bind directly on HSP90 which 
is upregulated in many cancers. Many proteins are also responsible 
for transformation of normal cells to cancerous cells. Coumarins 
also degrade cochaperone and proteins which ultimately results in 
antiproliferative effect. Coumarins are reported to cause in vivo and 
in vitro depletion of the key regulatory HSP90-dependent kinases 
including Src, Raf-1, and ErBB2-a protein in humans encoded by ErBB2 
gene [23].
Antimicrobial agents
The thioemicarbazones acts as a key intermediate in the novel 
preparation of important compounds with good antimicrobial 
activity such as thiazolidin-4-one derivatives. These thiazolidine-
4-one derivative possessed comparable activity to ampicillin and 
chloramphenicol at a concentration 25 μg/ml. Also, 4-methylcoumarin-
thiazolidine-4-one hybrids were reported to exhibit good antimicrobial 
activity; the thiazolidine-4-one had comparable activity to ciprofloxacin 
and griseofulvin at 10 μg/ml and the 4-methylcoumarin-thiazolidine-
4-one possessed potent antifungal activity with minimum inhibitory 
concentration value of 0.10 μg/ml. Therefore, the purpose of this work 
was to study the effect of hybridizing 7-hydroxy-4-methylcoumarin and 
their 7-alkoxy analogs with different N4-substituted thiosemicarbazone 
that were cyclized into the C5-substituted-thiazolidine-4-one ring. The 
antimicrobial activity of new compounds was evaluated [24].
Oxadiazole
Antimycobacterial activities
Macaev et al. had been reported with synthesis of 5-aryl-2-thio-1,3,4-
oxadiazole derivatives were screened for their antimycobacterial 
activities against Mycobacterium tuberculosis H37Rv [25].
Rane et al. had been reported with synthesis and antimicrobial 
evaluation of 42 novel 4-nitropyrrole-based 1,3,4-oxadiazoles. The 
synthesized molecules were evaluated for antibacterial, antifungal, and 
antitubercular activities [26].
Anticonvulsant activity
A series of new 2-substituted-5-(2-benzylthiophenyl)-1,3,4-
oxadiazoles was designed and synthesized as anticonvulsant agents. 
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The introduction of an amino group in position two of 1,3,4-oxadiazole 
ring and a fluoro substituent at para position of benzylthio moiety had 
the best anticonvulsant activity [27].
Antitumor activity
A series of 1,3,4-oxadiazole derivatives containing 1,4-benzodioxan 
moiety has been designed, synthesized, and evaluated for their 
antitumor activity. Most of the synthesized compounds were proved to 
have potent antitumor activity and low toxicity. Among them, compound 
7a showed the most potent biological activity against human umbilical 
vein endothelial cells [28].
Recently, some new 3-(2-methoxyphenylaminomethyl)-5-(2-
bromophenyl)-1,3,4-oxadiazoline-2-thione derivatives has been found 
to possess considerable anti-tumor agents property [29].
Anticancer activity
Chen et al. had been reported with the synthesis of novel hybrid 
molecules containing 1,3,4-oxadiazole and 1,3,4-thiadiazole bearing 
Schiff base moiety were designed, synthesized, and evaluated for their 
in vitro antitumor activities against SMMC-7721, MCF-7, and A549 
human tumor cell lines by CCK-8 assay [30].
Poojary et al. had been reported with the design, synthesis, and 
biological evaluation of a novel series of 1,3,4-oxadiazole bearing 
N-methyl-4-(trifluoromethyl-)phenyl pyrazole moiety as cytotoxic 
agents [31].
COUMARIN AND OXADIAZOLE HYBRIDS WITH DIFFERENT 
HETEROCYCLIC COMPOUNDS
Indolyl–coumarin hybrids
Sangshetti et al. [32] synthesized series of some new combination of 
hetrocycles having the coumarin and indole linked through chalcone-
like chain and same were evaluated in vitro antileishmanial activity. 
Since the entire three nucleuses were also found to possess antioxidant 
activities; therefore, their antioxidant screening too performed 
using DPPH-radical scavenging method. To clarify and understand 
the probable binding mode of synthesized compounds for their 
antileishmanial activity, the compounds were docked for possible 
targets for anti-leishmanial activity. We had also predicted their 
ADME properties in silico to suggest the suitability of any of the new 
compounds for further drug development.
Coumarin-chalcone hybrids
A series of coumarin-chalcone hybrids has been synthesized and 
evaluated for their in vitro cytotoxicity against a set of four human cancer 
cell lines and normal fibroblasts. Pingaew et al. synthesized two sets 
of coumarin chalcone derivatives (1,2) linked by a 1,2,3-triazole ring 
through the azide/alkyne dipolar cycloaddition and their cytotoxicity 
was screened in vitro against a panel of four cancer cell lines, including 
HuCCA-1 (cholangiocarcinoma), HepG2 (hepatocellular carcinoma), 
A549 (lung carcinoma) using MTT assay, and MOLT-3 (lymphoblastic 
leukemia) using XTT assay [15]. It was revealed that majority of the 
hybrid compounds showed cytotoxicity against MOLT-3 cells with IC50 
values ranging between 0.53 and 79.49 μM; among them, compounds 
bearing trimethoxy-substituted B-ring selectively inhibited growth 
of MOLT-3 cells. The most potential compound bearing 4-triazole on 
A-ring and 2,3-DiOCH3 on B-ring of (2) displayed significant cytotoxicity 
against HuCCA-1 (IC50 = 4.81 μM), followed by A549 (IC50=7.95 μM) 
and HepG2 (IC50 = 8.18 μM) with non-toxic to non-cancerous vitro cell 
line [33].
Coumarin-sulfonamide hybrid
Reddy et al. synthesized coumarin-3-(N-aryl)-sulfonamides. The effect 
of all the compounds on the growth of human tumor cells in culture was 
evaluated using androgen receptor negative prostate (DU145), non-
small cell lung carcinoma (H157), estrogen-receptor negative breast 
(BT20), colorectal (DLD-1), and chronic myeloid leukemia (K562) cell 
lines. The establishment of dose-response of each cell line was done 
by determining the number of viable cells after 96 hrs of continuous 
treatment against five different concentrations (1-100 μM range) of 
each compound. The activation of JNK1 by these compounds as shown 
in immune complex kinase assay clearly showed that they activate JNK 
pathway either by interacting with JNK1 or with one of the upstream 
kinases in this pathway [34].
Donepezil-coumarin hybrids
On combining the N-benzylpiperidine moiety of donepezil with 
coumarin into in a single molecule, novel hybrids with ChE and MAO-B 
inhibitory activity were designed and synthesized. The biological 
screening results indicated that the most of compounds displayed good 
potent inhibitory activity for AChE and BuChE, and clearly selective 
inhibition to MAO-B [35].
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Benzimidazole-oxadiazole hybrid
Depending on the heterocyclic nucleus of bendamustine, a series of four 
benzimidazole derivatives was designed and synthesized starting from 
4-(1H-benzo-imidazol-2-yl)-4-oxo-butanehydrazide. In the rational 
design of target molecules, the benzimidazole ring of bendamustine was 
retained and the bis-(chloroethyl) amine group (mechlorethamine) was 
substituted with several biologically active scaffolds such as oxadiazole, 
thiadiazole, and triazolothiadiazines, in the hope of obtaining novel 
cytotoxic agents with improved efficacy and safety. Cytotoxic activities 
of the designed analogs were carried out at the National Cancer Institute 
(NCI), USA, against full NCI 60 human cell lines [36].
Resveratrol-oxadiazole hybrid
Novel classes of resveratrol-oxadiazole hybrid compounds were 
synthesized to screen for their in vitro antiproliferative activity 
against human cancer cell lines. All the compounds showed good 
antiproliferative activity than the reference compound resveratrol. 
Resveratrol-oxadiazole hybrid compounds may possibly be used as 
a good leads for the development of new antiproliferative agents. 
Resveratrol-oxadiazole analogs were prepared from reaction of 
resveratrol bromides and with 1,3,4-oxadiazole-2-thiones. These two 
coupling partners resveratrol bromides and 1,3,4-oxadiazole-2-thiones 
were synthesized from commercially available starting materials [37].
Oxadiazole-benzohydrazone hybrids
A series of novel compounds consisting of oxadiazole-benzohydrazone 
hybrids was synthesized through a five-step reaction sequence 
and then evaluated for their β-glucuronidase inhibitory potential. 
β-glucuronidase is an enzyme that catalyzes cleavage of glucuronosyl-
O-bonds. This enzyme is involved in many diseases such as 
inflammation of joints such as rheumatoid arthritis. While in some 
cases, overexpression of this enzyme is reported to cause liver diseases 
and AIDS. Besides that, β-glucuronidase also plays an important role 
in diseases such as urinary tract infection, epilepsy, renal disease, 
rejection of transplantation, larynx, and breast. Various studies had 
been carried out to show that bacterial β-glucuronidase inhibitor 
decreases carcinogen-induced colonic tumors [38].
Quinoline-oxadiazole hybrids
Novel quinoline-oxadiazole hybrid compounds were designed 
based on stepwise rational modification of the lead molecules 
and to enhance bioactivity and improve drug likeness. The hybrid 
compounds synthesized were screened for biological activity against 
mycobacterium tuberculosis H37Rv and for cytotoxicity in HepG2 cell 
line [39].
CONCLUSION
Coumarin and oxadiazole derivatives have received increasing attention 
for their wide biological and pharmacological activities. We summarized 
the anti-inflammatory, anticoagulant, and anticancer activity for natural 
and synthesized coumarins and oxadiazoles. The anticancer effect 
of the coumarins and oxadiazoles is the most important one in these 
biological activities and the G-quadruplex interacting with coumarins 
may be a new target of the proto-oncogene for further cancer treatment 
and 1,3,4-oxadiazoles derivatives are also potent anticancer agents. The 
review is of importance for the design and development of the coumarin 
and oxadiazole derivatives as novel lead molecules for disease therapy.
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